The relationship between mental health disorders and substance use and integrated approaches.
Mental Health
Toolkit for practitioners working with families affected by co-occurring conditions
This toolkit has been produced by Adfam and family members affected by the co-occurring conditions of substance use disorders and mental ill-health. It is designed for practitioners who support those caring for a loved one who is having...

Managing Co-occuring Alcohol and Other Drug and Mental Health Conditions
This website provides evidence-based information, training and resources to assist with the management of co-occurring, or comorbid, AOD and mental health conditions. The content is based on the second edition of the “Guidelines on the...
Disruption to Mental Health Services Caused by COVID-19
A recent World Health Organisation (WHO) survey has found that 93% of countries worldwide have experienced significant disruption to mental health services. With a rise in demand for these services, these worring findings suggest there is...
Family, a Key Social Institution for Addressing Drug Abuse, Violence and Mental Health
64th Commission on Narcotic Drugs (CND), a virtual side event on “Family a key social institution for addressing substance use, violence, mental health and promote sustainable development: Lessons learned from parenting under stress, in humanitarian settings and in the context of COVID19 and beyond”
Tuesday 13th of April 2021, 13:10-14:00 CET
Evidence Review of Drug Treatment Services for People who are Homeless and Use Drugs
People who are homeless have complex and challenging lives. They tend to have worse physical and mental health than the general population. Substance use is more prevalent among people who are homeless than in the general population, and...

Smoking Cessation for Improving Mental Health- Cochrane Review
People with mental health issues are more likely to smoke compared to the general population. They are also more likely to experience severe withdrawals and are less responsive to treatment. Indeed, some people believe that quitting smoking...
A US national randomized study to guide how best to reduce stigma when describing drug‐related impairment in practice and policy
Drug‐related impairment is persistently stigmatized delaying and preventing treatment engagement. To reduce stigma, various medical terms (e.g. ‘chronically relapsing brain disease’, ‘disorder’) have been promoted in diagnostic systems and among national health agencies, yet some argue that over‐medicalization of drug‐related impairment lowers prognostic optimism and reduces personal agency.

Responding to drugs and homelessness. Innovative approaches in Europe
Objective: To explore innovative programmes providing solutions in the field of homelessness and drugs. Background: The association between long-term homelessness, problem drug use and alcohol dependence are well documented. Evidence...
Language matters: Contemporary discursive constructions of alcohol use.
Wednesday 17th February 2020, 1-2pm
